General & Plastic Surgery Devices - Norway

In Norway, the General & Plastic Surgery Devices market market is anticipated to witness a substantial growth in revenue, with projections indicating a staggering figure of US$97.22m in 2024.
Furthermore, it is expected that this market will continue to expand at an annual growth rate of 2.87%, resulting in a market volume of US$112.00m by 2029.
When comparing these figures to the global market, it is worth noting that the United States is expected to generate the highest revenue, reaching an impressive US$9.84bn in 2024.
Norway's demand for General & Plastic Surgery Devices in the Medical Technology market is driven by a growing emphasis on aesthetic procedures and advanced surgical techniques.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Norway has been experiencing steady growth in recent years. Customer preferences in Norway are shifting towards non-invasive procedures and minimally invasive surgeries. This is driven by a desire for quicker recovery times, less scarring, and less pain. Patients are increasingly opting for procedures such as Botox injections, dermal fillers, and laser treatments, which offer immediate results with minimal downtime. Additionally, there is a growing demand for body contouring procedures, such as liposuction and abdominoplasty, as people strive to achieve their desired body shape. Trends in the market indicate a growing focus on technological advancements. Norway is known for its high-tech healthcare system, and this extends to the field of general and plastic surgery devices. Surgeons and patients alike are seeking out devices that offer the latest innovations, such as robotic-assisted surgical systems and 3D imaging technology. These advancements not only improve the precision and safety of procedures but also enhance the overall patient experience. Local special circumstances in Norway contribute to the development of the General & Plastic Surgery Devices market. The country has a high standard of living and a strong emphasis on healthcare. The government invests heavily in medical research and development, which creates a favorable environment for the introduction of new devices and technologies. Additionally, Norway has a well-regulated healthcare system, with strict quality standards and regulations in place. This provides assurance to both patients and healthcare professionals regarding the safety and efficacy of the devices used in general and plastic surgery. Underlying macroeconomic factors also play a role in the growth of the market. Norway has a prosperous economy, with a high GDP per capita and a strong healthcare infrastructure. The country's aging population is driving the demand for general and plastic surgery procedures, as individuals seek to maintain a youthful appearance and address age-related concerns. Furthermore, increasing disposable incomes and a growing awareness of cosmetic procedures are contributing to the expansion of the market. In conclusion, the General & Plastic Surgery Devices market in Norway is developing in response to customer preferences for non-invasive and minimally invasive procedures, as well as advancements in technology. Local special circumstances, such as a high standard of living and a well-regulated healthcare system, further support the growth of the market. Underlying macroeconomic factors, including a prosperous economy and an aging population, also contribute to the expansion of the market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.